@usstocksnews | YouTube | VK Видео | Чат
Adjusted EPS $1.86, est. $1.78
Net revenue $15.78b, est. $15.59b
Skyrizi revenue $4.71b, est. $4.58b
Rinvoq revenue $2.18b, est. $2.16b
Humira revenue $993m, est. $1.14b
Imbruvica revenue $706m, est. $722.4m
Sees FY adjusted EPS $10.61 to $10.65, saw $10.38 to $10.58
#abbv
Для обсуждения переходи в чат t.me/USstocksnews_chat
